Rat hepatic stellate cells alter the gene expression profile and promote the growth, migrationand invasion of hepatocellular carcinoma cells

Molecular Medicine Reports

Volumn 10, Issue 4, 2014, Pages 1725-1733

  Wang, Zhi Ming ^a   Zhou, Le Yuan ^a   Liu, Bin Bin ^a   Jia, Qin An ^a   Dong, Yin Ying ^a   Xia, Yun Hong ^a   Ye, Sheng Long ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CDNA microarray; Hepatocellular carcinoma; HSCs; Matrix metalloprotein 2, 9

Indexed keywords

GELATINASE A; GELATINASE B; SCATTER FACTOR; TRANSCRIPTOME;

ALLOTRANSPLANTATION; ANIMAL; BUFFALO RAT; CARCINOGEN TESTING; CELL LINE; CELL MOTION; CELL PROLIFERATION; COCULTURE; CYTOLOGY; DNA MICROARRAY; FEMALE; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; PATHOLOGY; RAT; STELLATE CELL;

ANIMALS; CARCINOGENICITY TESTS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; FEMALE; HEPATIC STELLATE CELLS; HEPATOCYTE GROWTH FACTOR; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED BUF; TRANSCRIPTOME; TRANSPLANTATION, HOMOLOGOUS;

EID: 84924219888     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2435     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
2. Friedman SL: Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 32: 424-430, 1997.
3. Elsharkawy AM and Mann DA: Nuclear factor-kappa B and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46: 590-597, 2007. (Pubitemid 47344795)
4. Wong CM and Ng IO: Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28: 160-174, 2008.
5. Chau KY, Lily MA, Wu PC and Yau WL: Myofibroblasts in hepatitis B related cirrhosis and hepatoellular carcinoma. J Clin Pathol 45: 446-448, 1992.
6. Bridle KR, Crawford DH, Powell LW and Ramm GA: Role of myofibroblasts in tumor encapsulation of hepatocelluar carcinoma in haemochromatosis. Liver 21: 96-104, 2001. (Pubitemid 32409536)
7. Terada T, Makimoto K, Terayama N, Suzuki Y and Nakanuma Y: Alpha-smooth muscle actin-positive stroma cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver careinomas. J Hepatol 24: 706-712, 1996.
8. Olaso E, Salado C, Egilegor E, et al: Proangiogenic role of tumor-activated HSCs in experimental melanoma metastasis. Hepatology 37: 674-685, 2003. (Pubitemid 36258789)
9. Zhao W, Zhang L, Yin Z, et al: Activated HSCs promote hepatocellular carcinoma development in immunocompetent mice. Int J Cancer 129: 2651-2661, 2011.
10. Xia Y, Chen R, Song Z, Ye S, Sun R, Xue Q and Zhang Z: Gene expression profiles during activation of cultured rat HSCs by tumoral hepatocytes and fetal bovine serum. J Cancer Res Clin Oncol 136: 309-321, 2010.
11. Weiskirchen R and Gressner AM: Isolation and culture of HSCs. Methods Mol Med 117: 99-113, 2005.
12. Geerts A: On the origin of stellate cells: mesodermal, endodermal or neuro-ectodermal? J Hepatol 40: 331-334, 2004.
13. Bachem MG, Meyer D, Melchior R, Sell KM and Gressner AM: Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 89: 19-27, 1992.
14. Rockey DC, Boyles JK, Gabbiani G and Friedman SL: Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 4: 193-203, 1992.
15. Amann T, Bataille F, Spruss T, et al: Activated HSCs promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100: 646-653, 2009.
16. Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P and Rosenbaum J: Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology 26: 1458-1466, 1997. (Pubitemid 27520010)
17. Meindl-Beinker NM, Katsuzaki K and Dooley S: TGF-β signaling in the onset and progression of hepatocellular cancer. Dig Dis 30: 514-523, 2012.
18. Ogunwobi OO and Liu C: Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metast 28: 721-731, 2011.
19. Santomato A, Franseva E, Dituri F, et al: HSCs stimulate HCC cell migration via laminin-5 production. Clin Sci (Lond) 121: 159-168, 2011.
20. Kim SW, Kim JS, Papadopoulos J, et al: Consistent interactions between tumor cell IL-6 and macrophage TNF-alpha enhance the growth of human prostate cancer cells in the bone of nude mouse. Int Immunopharmacol 11: 862-872, 2011.
21. Kao JT, Lai HC, Tsai SM, et al: Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients. Liver Int 32: 928-936, 2012.
22. Okazaki I and Inagaki Y: Novel strategies for hepatocellular carcinoma based on MMPs science. Anticancer Agents Med Chem 12: 753-763, 2012.